Vienna-based Flinn.ai, which automates medtech quality and regulatory processes for faster product launches, has raised €6 million in a seed round to revolutionize Medtech compliance and quality with AI. The round was led by Cherry Ventures, with participation from existing investors Speedinvest and SquareOne Venture Capital.
- Co-founded in 2022 by Bastian Krapinger, Ruther Markus Müller, and Hasib Samad, Flinn.ai develops AI-driven solutions to automate quality and regulatory compliance processes for MedTech companies.
- Flinn.ai enables medical device manufacturers to launch high-quality products 10x faster by streamlining processes and ensuring full regulatory compliance.
- The startup's first product automates Post-Market Surveillance (PMS) using AI to collect data in one tool, integrate with quality management and regulatory systems, and efficiently evaluate results. It also generates MDR-compliant reports automatically, reducing manual work and ensuring full regulatory compliance.
Details of the deal
- The seed round was led by Cherry Ventures, a Berlin-based venture capital firm that backs European tech founders tackling critical societal, environmental, and business challenges. With offices in Berlin, London, and Stockholm, the firm boasts a portfolio of notable companies, including FlixBus, Auto1, Forto, Tacto, Qualifyze, Juni, Moss, and Carbo Culture.
- Existing investors Speedinvest, a Vienna-based venture capital firm managing over €1 billion in assets, and Berlin-based VC SquareOne Venture Capital participated in the round.
“Flinn is quickly becoming the go-to regulation & compliance co-pilot for leading medtech manufacturers. We have been privileged to see Markus, Bastian, and Hasib turn their vision into reality since day 1, putting customers at the heart of every stage of their product development process. This new round is a well-deserved on top," Partner with Speedinvest's Health and TechBio tea, Andrea Zitna, stated.
- The investment will enable Flinn.ai to help health product creators build high-quality products 10x more efficiently by automating post-market surveillance and streamlining compliance processes.
